Biotech

All Articles

ArsenalBio raises $325M, rotates far from previous lead resource

.Collection Biosciences is actually carrying on up. The tissue therapy company has actually added on...

Lilly- backed effective weight loss biotech documents IPO

.After raising $170 thousand back in February, metabolic disease-focused BioAge Labs has filed to de...

Aelis' cannabis use medicine flunks period 2b, driving Indivior to reconsider $100M option

.Aelis Farma's hopes of securing a quick, good decision on a $100 thousand option remittance have fa...

ProKidney standstills phase 3 test certainly not needed to have for tissue treatment authorization

.ProKidney has actually ceased among a set of period 3 trials for its tissue treatment for kidney di...

Vaxcyte rises on 'stunning' 31-valent PCV gain against Pfizer

.Vaxcyte revealed what experts referred to as "stunning" period 1/2 data for its own 31-valent pneum...

Recursion's human brain condition trial reveals scant proof of efficiency

.Recursion has actually stumbled with an early test of its own tech-enabled technique to medication ...

Acepodia, Pfizer click with each other for chemistry-based tissue therapy

.Call it a situation of great chemistry: Acepodia, a biotech based upon Nobel Champion scientific re...

Praxis epilepsy medication decreases confiscations in phase 2 hearing

.Praxis Precision Medicines has actually scored yet another midphase gain in epilepsy this year, alo...

Three officers resign as Dyne messages mixed data for DMD prospect

.After running away a clinical grip several years back, Dyne Therapy has actually disclosed new phas...

Arrowhead fires off period 3 information in uncommon metabolic illness in advance of market clash with Ionis

.Arrowhead Pharmaceuticals has revealed its own hand before a potential face-off along with Ionis, r...